Mary Newland, Charles C Lee, Cindy Li, Ashley Sun, John Potochny
{"title":"Incidence of Post Operative VTE following Panniculectomy in Patients with History of COVID-19.","authors":"Mary Newland, Charles C Lee, Cindy Li, Ashley Sun, John Potochny","doi":"10.1097/PRS.0000000000012202","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Venous thromboembolism (VTE) is a well-documented post operative complication with potentially life-threatening sequela. While the risk of VTE in plastic surgery patients is low, these devastating consequences pose a critical need for assessment of risk factors in elective operations. Recent research has elucidated that a history of COVID-19 infection may be an additional predisposing risk factor to VTE formation. Therefore, our study aims to assess the risk of VTE in panniculectomy patients with the history of COVID-19.</p><p><strong>Methods: </strong>The TriNetX LLC. National Health Research database, which collects data from hospitals within the United States, was queried to identify patients who underwent panniculectomy in the years 2017-2020 (pre-pandemic) and 2020-2023 (post-pandemic). Mandatory testing and reporting offered a unique opportunity to capture the ICD-10 COVID diagnosis during the study period. Post-pandemic patients were studied by querying the data to look for those with a history of COVID versus those without. These cohorts were analyzed to calculate the incidence rate of VTE in the 30 day post operative period.</p><p><strong>Results: </strong>A total cohort of 7,114 patients who underwent panniculectomy on prophylactic anticoagulation - a treatment for VTE - were identified. There were 3,015 patients in the pre-pandemic category and 4,099 patients in the post-pandemic group. Within the post-pandemic classification, there were 790 patients with a prior history of COVID and 3,309 patients without. The rate of VTE was not significantly different in the pre (3.2%) versus post (3.0%) pandemic cohorts (p=0.64). However, in the post-pandemic cohort, there was a significant difference in VTE rates between patients with (4.9%) and without (2.5%) prior history of COVID (p= 0.0002).</p><p><strong>Conclusion: </strong>Our study showed there was no significant increase in VTE incidence after panniculectomy during the pandemic. However, in the subpopulation of patients identified with a COVID diagnosis, we observed a significantly higher rate of VTE compared to panniculectomy patients without a diagnosis of COVID. Therefore, patients with a history of COVID may be more susceptible to postoperative VTEs. Seeing as its true long-term morbidity effects are yet to be fully understood, a history of COVID should be carefully considered when determining a patient's VTE risk. This data thereby warrants further study for optimal perioperative and postoperative anticoagulation strategies.</p>","PeriodicalId":20128,"journal":{"name":"Plastic and reconstructive surgery","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plastic and reconstructive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PRS.0000000000012202","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Venous thromboembolism (VTE) is a well-documented post operative complication with potentially life-threatening sequela. While the risk of VTE in plastic surgery patients is low, these devastating consequences pose a critical need for assessment of risk factors in elective operations. Recent research has elucidated that a history of COVID-19 infection may be an additional predisposing risk factor to VTE formation. Therefore, our study aims to assess the risk of VTE in panniculectomy patients with the history of COVID-19.
Methods: The TriNetX LLC. National Health Research database, which collects data from hospitals within the United States, was queried to identify patients who underwent panniculectomy in the years 2017-2020 (pre-pandemic) and 2020-2023 (post-pandemic). Mandatory testing and reporting offered a unique opportunity to capture the ICD-10 COVID diagnosis during the study period. Post-pandemic patients were studied by querying the data to look for those with a history of COVID versus those without. These cohorts were analyzed to calculate the incidence rate of VTE in the 30 day post operative period.
Results: A total cohort of 7,114 patients who underwent panniculectomy on prophylactic anticoagulation - a treatment for VTE - were identified. There were 3,015 patients in the pre-pandemic category and 4,099 patients in the post-pandemic group. Within the post-pandemic classification, there were 790 patients with a prior history of COVID and 3,309 patients without. The rate of VTE was not significantly different in the pre (3.2%) versus post (3.0%) pandemic cohorts (p=0.64). However, in the post-pandemic cohort, there was a significant difference in VTE rates between patients with (4.9%) and without (2.5%) prior history of COVID (p= 0.0002).
Conclusion: Our study showed there was no significant increase in VTE incidence after panniculectomy during the pandemic. However, in the subpopulation of patients identified with a COVID diagnosis, we observed a significantly higher rate of VTE compared to panniculectomy patients without a diagnosis of COVID. Therefore, patients with a history of COVID may be more susceptible to postoperative VTEs. Seeing as its true long-term morbidity effects are yet to be fully understood, a history of COVID should be carefully considered when determining a patient's VTE risk. This data thereby warrants further study for optimal perioperative and postoperative anticoagulation strategies.
目的:静脉血栓栓塞(VTE)是一种有充分文献记载的术后并发症,其后遗症可能危及生命。虽然整形手术患者静脉血栓栓塞的风险很低,但这些毁灭性的后果对择期手术的风险因素评估提出了迫切的需要。最近的研究表明,COVID-19感染史可能是静脉血栓形成的另一个易感危险因素。因此,我们的研究旨在评估有COVID-19病史的输卵管切除术患者发生静脉血栓栓塞的风险。方法:查询TriNetX LLC. National Health Research数据库,该数据库收集了来自美国各医院的数据,以确定2017-2020年(大流行前)和2020-2023年(大流行后)期间接受胰腺切除术的患者。在研究期间,强制性检测和报告为捕获ICD-10 COVID诊断提供了独特的机会。通过查询数据来寻找有COVID病史的患者和没有COVID病史的患者,研究了大流行后的患者。对这些队列进行分析,计算术后30天静脉血栓栓塞的发生率。结果:7114名接受血管导管切除术预防性抗凝治疗(静脉血栓栓塞的一种治疗方法)的患者被确定。大流行前组有3015名患者,大流行后组有4099名患者。在大流行后分类中,有790名患者有COVID病史,3309名患者没有。静脉血栓栓塞率在大流行前(3.2%)和大流行后(3.0%)组无显著差异(p=0.64)。然而,在大流行后队列中,有(4.9%)和没有(2.5%)COVID病史的患者的静脉血栓栓塞率存在显著差异(p= 0.0002)。结论:我们的研究显示,大流行期间胰管切除术后静脉血栓栓塞发生率没有显著增加。然而,在诊断为COVID的患者亚群中,我们观察到与未诊断为COVID的输卵管切除术患者相比,VTE的发生率显着更高。因此,有COVID病史的患者可能更容易发生术后静脉血栓栓塞。鉴于其真正的长期发病率影响尚未完全了解,在确定患者的静脉血栓栓塞风险时,应仔细考虑COVID的病史。因此,这些数据值得进一步研究最佳围手术期和术后抗凝策略。
期刊介绍:
For more than 70 years Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. Plastic and Reconstructive Surgery® , the official journal of the American Society of Plastic Surgeons, is a benefit of Society membership, and is also available on a subscription basis.
Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, cosmetic surgery, as well as news on medicolegal issues. The cosmetic section provides expanded coverage on new procedures and techniques and offers more cosmetic-specific content than any other journal. All subscribers enjoy full access to the Journal''s website, which features broadcast quality videos of reconstructive and cosmetic procedures, podcasts, comprehensive article archives dating to 1946, and additional benefits offered by the newly-redesigned website.